Back

De novo conduction disturbances after TAVI: what to expect?

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Cutting edge transcatheter heart failure therapeutics Intervention HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Debora Da Silva Correia

Hospital Santa Cruz, Lisbon (Portugal)

5 More presentations in this session

Presentation thumbnail
Tricuspid regurgitation in patients undergoing mitral valve surgery for primary mitral regurgitation
Assistant Professor K. Lodin (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Risk assessment in patients with low-flow, low-gradient aortic stenosis undergoing TAVI
Doctor M. Caetano Coelho (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Impact of treatment modality on prognostic features in patients with severe tricuspid regurgitation
Doctor K. Kresoja (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
Two-year outcomes of mitral transcatheter edge-to-edge repair in patients with heart failure and functional mitral regurgitation from the MiCLASP Study
Doctor K. Rommel (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
Impact of ejection fraction based heart failure classification on TAVI related outcomes
Doctor Y. Sener (Rotterdam, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Cutting edge transcatheter heart failure therapeutics

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Conduction disturbances following transcatheter aortic valve implantation: clinical predictors and prognostic implications of post-procedural pacemaker implantation
thumbnail
Congress Presentation
Pacing burden and its development over time in patients with permanent pacemaker implantation following TAVI
thumbnail
Congress Presentation
Impact of conduction disturbances persistency on 2-year outcomes after transcatheter aortic valve implantation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources